Highlights Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Market Closed - Nasdaq Helsinki Other stock markets 11:29:52 2024-05-21 am EDT			5-day change	1st Jan Change
1.64 ^EUR	+3.14%		+0.61%	+46.95%

Apr. 16	Finland’s Nightingale Health Plots US Expansion	MT
Apr. 16	Nightingale Health to Establish A Laboratory in the United States	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Finland’s Nightingale Health Plots US Expansion	Apr. 16	MT
Nightingale Health to Establish A Laboratory in the United States	Apr. 16	CI
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States	Apr. 16	CI
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation	Apr. 12	MT
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc	Apr. 12	CI
Nightingale Health Closes Purchase of Japan's Welltus	Mar. 29	MT
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	Mar. 28	CI
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort	Mar. 19	CI
Finland-based Nightingale Health to Buy Japan's Welltus	Mar. 07	MT
Nightingale Health Oyj Reports Earnings Results for the Half Year Ended December 30, 2023	Mar. 07	CI
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	Mar. 06	CI
Nightingale Health Lands Five New Health Risk Detection Patents in Finland	Jan. 31	MT
Nightingale Health plc Receives Five New Patents for Its Proprietary Health Risk Detection Capability	Jan. 31	CI
Suomen Terveystalo Begins Using Nightingale Health's Blood Analysis Technology in Regular Health Checks in Occupational Health	Jan. 02	CI
Terveystalo Integrates Nightingale Health's Blood Analysis Technology in Occupational Health	Jan. 02	MT
Nightingale Health Completes the Analysis of All 500,000 UK Biobank Samples Creating the Largest Blood Biomarker Database for Chronic Disease Research and Prevention	Dec. 13	CI
Nightingale Health and Innoquest Diagnostics Enter into Collaboration Agreement to Make Nightingale Health's Technology Accessible in the Southeast Asia Region	Nov. 15	CI
Nightingale Health Oyj Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-28	CI
Nightingale Health Secures Three New Patents in Finland	23-09-26	MT
Nightingale Health Receives Three New Patents Further Strengthening Its IP Portfolio	23-09-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Highlights

Filters